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Abstract: Artificial nucleases are designed for in vivo gene engineering, as the DNA cleavage per-
formed at a specific target site enhances the effectiveness of the cell’s DNA repair machinery. The 
therapeutic potential of the above phenomenon stems from the knowledge that (i) the shifted reading 
frame can be restored by non-homologous end-joining, or (ii) a DNA of erroneous sequence – causing 
a genetic disease – can be corrected by homologous recombination in the presence of a suitable DNA 
template. Besides the advantageous properties of the nowadays applied zinc finger nucleases, TALE 
nucleases and the CRISPR/Cas9 system, they possess a residual citotoxicity. This is related to off-
target cleavages, which could be prevented by the strict regulation of the enzymes. The studies on enzymes acting natu-
rally in a controlled manner are beneficial to get better insight into their mechanism. Such enzymes or their appropriate 
domains may be the most promising alternatives to the presently applied ones. As an example, the DNA cleavage of the 
inactive HNH nuclease mutants is inducible in a multiple way. This property may be used for establishing a control 
mechanism and thus, in combination with specific DNA-binding domains they are good candidates for the catalytic site of 
artificial nucleases. Here we collect the results on the properties of the HNH nucleases that allow for their redesign into 
enzymes with possible therapeutic applications. 
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1. INTRODUCTION 
Artificial nucleases are designed for specific gene engi-
neering, which would otherwise be impossible with the 
available arsenal of the native enzymes. One of the most 
promising application of these agents is gene therapy [1-5], 
but they are also used for gene modifications in cells to cre-
ate animal models [6,7], to improve properties of plants (e.g. 
targeted addition of a herbicide-tolerance gene [8]) [9,10], 
and to broaden our knowledge on genetic phenomena [11]. 
The basis of these experiments is that the double-strand 
cleavage of DNA induces the cells’ repair machinery to cor-
rect the damaged molecule. By the help of the subsequent 
processes (i) the shifted reading frame can be restored or a 
random mutation can be induced for gene knockout purpose 
by non-homologous end-joining, or (ii) a DNA of erroneous 
sequence – causing a genetic disease – can be corrected, or a 
gene can be inserted in a targeted way by homologous recom-
bination in the presence of a suitable DNA template [12-21]. 
Because of this large scientific potential, there is a high de-
mand of constructing specific artificial nucleases, as it is 
demonstrated by the continuously increasing number of pub-
lications on this hot topic.  
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2. CURRENT ARTIFICIAL NUCLEASES 
One large group of artificial nucleases are the synthetic 
catalytic agents, mostly metal complexes, with all their ad-
vantages and drawbacks discussed in detail elsewhere [5,22-
25]. The other class of the designed enzymes includes modi-
fied versions of native proteins constructed either by intro-
ducing mutations through molecular design or directed evo-
lution methods or by creating chimera from independent 
catalytic and DNA binding domains. The main strategies 
applied in these experiments on artificial meganucleases 
constructed from homing endonucleases, zinc finger nucle-
ases (ZFNs), transcription activator-like effector nucleases 
(TALENs) and clustered regularly interspaced short palin-
dromic repeats (CRISPR) with associated nucleases (Cas) 
were discussed in several recent reviews [26-33].  
The success of gene editing with artificial nucleases 
quickly led to a human clinical trial with zinc finger/FokI 
nucleases [34]. Although the infusion of the autologous CD4 
T-cells in which the CCR5 gene was inactivated by ZFNs 
proved to be safe within the limit of the mentioned study, we 
must be aware of possible side-effects of the artificial nucle-
ases, which may arise from the off-target binding of the ap-
plied DNA recognition domains and unwanted DNA cleav-
age [32,33,35,36]. Since the first successful construction of a 
modular zinc finger nuclease [37] the most widely applied 
protein chimera utilize the functional FokI nuclease domain 
as their cleavage agent [38], which can only function upon 
dimerization on DNA. The relatively short recognition se-
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quence (9-12 base pairs) of each DNA binding domains may 
cause cleavages at off-target sites by weak interactions of 
one of the monomers with a non-specific site, or by DNA 
looping [39]. The off-target DNA binding may be further 
enhanced by any damage of the DNA recognition domain 
within the cell. It has to be mentioned that the same phenom-
ena are excluded in the native FokI enzyme, as it acts in a 
controlled manner, the nuclease domain being under the al-
losteric inhibition of the DNA binding domain until the spe-
cific target sequence is recognized [40,41]. This advanta-
geous property is, however, lost when this nuclease domain 
is fused to different DNA-binding domains.  
Efforts have been put to improve the specificity and cyto-
toxic properties of the artificial enzymes. The redesign of the 
dimerization interface [42], construction of single chain 
quasi dimer nucleases [43] and context dependent assembly 
of the recognition motifs [44] represent examples of these 
attempts. The introduction of TALEs and later CRISPRs as 
DNA recognition domains led to the decrease of the the side-
effects [32,33,45]. Engineering nicking enzymes in all kinds 
of the chimeric artificial nucleases also resulted in a substan-
tial progress of this field [46-52]. Alternative nuclease do-
mains have been applied in few cases in mainly monomeric 
chimera [53-58] and non-FokI-based zinc finger nucleases 
have also been developed by introducing mutations or small 
modifications into the zinc finger array, such as the exchange 
of the metal ion-binding cysteines to histidines [59-61]. Tri-
als to establish controlled artificial nucleases through light-
activation [62,63], DNA binding [64], cold-shock technique 
[65], protein-protein interaction [66], DNA modification [67] 
or metal ion dependent DNA binding [68] were also exe-
cuted. Bioinformatics was utilized to predict ZFN and 
TALEN off-target cleavage [69]. 
3. HNH NUCLEASES 
It is obvious that the previously described experiments 
are still in progress yet without clear reassuring outcome 
concerning the application in human therapy. This fact in-
spired a search for specific class of the nuclease domains 
with the potential to turn these agents into engineered protein 
chimera, combining them with DNA binding domains so that 
they can act in controlled manner. The latter property is in-
dispensable for their eventual future therapeutic application, 
as it was shown above. Possible candidates could be among 
the nucleases with catalytic domains, which are dependent 
on allosteric features in their catalytic mechanism. 
According to the topography of their catalytic sites super-
families have been identified among the nucleases, such as 
the PD-(D/E)XK, HNH, LAGLIDADG and GIY-YIG 
groups of the enzymes [70-73]. While the catalytic residues 
vary largely among the members of most of the families, 
their identity and position within the HNH superfamily 
[70,71,74,75] is well conserved. This superfamily includes a 
number of specific enzymes (e.g. the I-HmuI [76] and I-PpoI 
[74] group I. homing endonucleases or Eco31I [77] HphI 
[78], KpnI [79,80], MnlI [81], Hpy99I [82], PacI [83] restric-
tion endonucleases) the RNA guided Cas9 nuclease [84,85] 
and nonspecific enzymes (e.g. Nuclease A [86], Serratia nu-
clease [74], Vvn [87], CAD - caspase-activated DNase [88] 
and bacterial toxins – colicins [89] and pyocins [90]). Their 
sequences can be found in the Pfam [72] and HNH [91] da-
tabases, the latter dividing the proteins into 10 subgroups. 
3.1. Structure of the HNH Motif 
The HNH motif consists of two β-strands and an α-helix 
connected with flexible loops. It is structurally resembling to 
the well-known zinc-finger motif (also possessing a ββα-
metal binding structure [92]) but its function is different. The 
classical active site of the HNH nucleases is characterized by 
a HX10-17NX6-11(H/N) motif, where X stands for any amino 
acid with the exception of those with side-chains for strong 
metal ion binding or proline. The first histidine (H) among 
the highly conserved residues behaves as a general base in 
DNA hydrolysis generating the nucleophile that attacks the 
scissile phosphodiester bond [70,84,93]. The following as-
paragine (N) plays a structural role, stabilizing the structure 
of the motif and positioning the catalytic histidine through 
extensive hydrogen-bonding network [70,94,95].  
 
Fig. (1). The structure of the HNH (left: PDB ID 1M08) and HNN 
(right: PDB ID 2QNC) motifs.  
The last conserved amino acid, which can either be a his-
tidine or asparagine (H/N), serves for the metal ion binding. 
Mg2+ or Zn2+ is suggested in most of the cases to be the cata-
lytically active cofactor. The nucleases such as e.g. the I-
HmuI HNH homing endonuclease [76], PacI restriction en-
donuclease [83], T4 endonuclease VII [93], Cas9 nuclease 
[84,85] contain Mg2+ in the active site bound to the con-
served second asparagine residue from HNN motif (Fig. 1). 
On the other hand HNH nucleases offering histidines for 
metal ion binding prefer transition metal ions, such as Zn2+ 
in their active centre. Examples are provided by e.g. the bac-
teriophage P1 nuclease [66] and colicin E7 [96,97]. 
The I-PpoI His-Cys box and the I-CreII GIY-YIG hom-
ing endonucleases have the specific feature to possess an 
HNH motif beside their motifs characteristic for different 
superfamilies. The former contains two Zn2+-ions [98,99] 
within the His-Cys box motifs, but its HNH-like active cen-
tre can be activated by Mg2+, Ca2+, Co2+ or Zn2+ [70]. The 
cleavage pattern of I-CreII is characteristic for the GIY-YIG 
enzymes, but the enzyme with mutated GIY-YIG residues 
proved to be still active in the presence of Zn2+ or Mg2+, un-
like upon the mutation at the conserved histidine residues of 
the HNH motif [100]. 
3.2. Nuclease Colicins 
Nuclease colicins are plasmid encoded bacterial toxins 
produced by Escherichia coli to provide protection from re-
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lated bacteria or bacteriophages by degradation of their 
chromosomal DNA [89, 101,102]. E-type colicins share the 
BtuB receptor to enter the target cell [103,104]. The C-
terminal nuclease domains of the Colicin E2, E7, E8 and E9 
(NColEs) serve as non-specific metallonucleases. Based on 
the topography of their active centre, these enzymes belong 
to the HNH superfamily of nucleases, showing high se-
quence similarity (Scheme 1) with the HHX14NX8HX3H 
general sequence near their C-termini [105]. These nuclease 
colicins are the most widely investigated HNH enzymes. 
 
KRNKPGKATGKGKPVNNKWLNNAGKDLGSPVPDRIANKLRDKEFKSFDDFRKKFWEEVSKDPELSKQF 
KRNKPGKATGKGKPVGDKWLDDAGKDSGAPIPDRIADKLRDKEFKSFDDFRKKFWEEVSKDPELSKQF 
KRNKPGKATGKGKPVGDKWLDDAGKDSGAPIPDRIADKLRDKEFKNFDDFRKKFWEEVSKDPDLSKQF 
GRDLPGKVTGTGTDVEGSWLAGAGEGLGAPVPTRIADRLRDREFSSFDAFRRSFWQEVAADPELAGQF 
 
SRNNNDRMKVGKAPKTRTQDVSGKRTSFELHHEKPISQNGGVYDMDNISVVTPKRHIDIHRGK-576 
KDSNKTNIQKGKAPFARKKDQVGGRERFELHHDKPISQDGGVYDMDNIRVTTPKRHIDIHRGK-581 
KGSNKTNIQKGKAPFARKKDQVGGRERFELHHDKPISQDGGVYDMNNIRVTTPKRHIDIHRGK-582 
KKGNQGRMKKGLAPRVRELEQAGKRHSTELHHVDLISDGGEVYNIDNIHVVTPKQHVEIHSGK-617 
Scheme 1. Multiple alignment of the sequences of nuclease do-
mains of selected bacterial toxins (line 1: colicin E7, line 2: colicin 
E2, line 3: colicin E9 and line 4: S-type pyocin) is shown for identi-
fication of the conserved amino acids. The C-terminal sequence 
encompassing the catalytic HNH motif is underlined. 
DNase colicins establish strong nonspecific interaction 
with the DNA within the major groove. At the same time, the 
catalytic HNH motif is located in the minor groove of the 
substrate [89,96,106-109]. The HNH motif formed by the C-
terminal ~ 45 residues coordinates a single metal ion by the 
imidazole side-chains of three histidines (e.g. by H544, H569 
and H573 in NColE7) in a distorted tetrahedral coordination 
sphere. This arrangement allows for the binding of a water 
molecule that can be exchanged to the phosphodiester group 
of DNA. Thus, the metal ion within the active site becomes 
close to the scissile phosphodiester group suggesting that it 
directly participates in the catalytic process. Indeed, the 
presence of the metal ions is essential for the catalytic activ-
ity [97]. For NColE7 Zn2+ [96,105] was suggested to be the 
physiological metal ion, but there is still a debate about the 
quality of metal ions in colicin nucleases [89,96,109-117]. 
The apo NColE7 e.g. could be reactivated to a different ex-
tent by Mn2+, Ni2+, Co2+, Cu2+, Mg2+, Ca2+ and Sr2+ [97,105]. 
The metal ion having a free coordination site may have es-
sential multiple roles in DNA-cleavage: it binds to the scis-
sile phosphodiester, polarizes the P-O bond for nucleophylic 
attack and stabilizes the phosphoanion transition state and/or 
the leaving group. It is also common among hydrolases that 
the metal ion activates a water molecule either for nucleo-
philic attack, or for the protonation of the laving group. The 
former function in HNH nucleases is supposed to be gener-
ated by the most conserved His residue - not coordinating to 
the metal ion - as already mentioned above.  
Colicins are simultaneously expressed with their immu-
nity proteins to protect the host cell. These proteins inhibit 
the interaction of colicin nuclease domains with DNA by 
establishing charge complementarity interactions with the 
nuclease [105, 118-124]. Thus, most of the investigated 
colicin nuclease domains have been prepared together with 
their immunity proteins independently of whether they were 
active and inactive. The consequence of this is multiple: (i) 
The solution of the nuclease/immunity protein complex must 
be acidified in order to separate the proteins. Under such 
conditions the metal ion is lost from the nuclease. This raises 
the question of the quality of the bound metal ion. (ii) The 
immunity protein, as well as, the DNA substrate has been 
demonstrated to induce the proper folding of the mutated 
nuclease domain [125,126]. Thus, even if the mutation 
would affect the structure of the nuclease domain itself, this 
can not be detected in the presence of the immunity protein 
or the substrate.  
Crystal structures of selected HNH nucleases showed a 
common feature of having a positively charged amino acid 
side-chain outside the HNH sequence, but spatially close to 
the active site. Examples are, e.g. the Vvn endonuclease 
(PDB ID 1OUP) [87], Sm endonuclease (PDB ID 1G8T) 
[127], Nuclease A (PDB ID 1ZM8) [86] NColE7 (PDB ID 
3FBD) [108]. R57 has been identified by a mutational analy-
sis in the Serratia nuclease to be essential for catalysis [74, 
128]. Previous studies also demonstrated that the catalytic 
activity of NColE7 drops to a low level or is completely can-
celled upon modification or deletion of the positively 
charged N-terminal amino acids [116,129,130]. The arginine 
residue being distal in the amino acid sequence, but becom-
ing spatially close to the active site is a conserved amino 
acid, a common feature of the HNH nucleases. The role of 
this amino acid may be multiple. It has been suggested to 
bind and stabilize the cleaved phosphate product [131]. As 
the presence of this residue or any positively charged residue 
potentially replacing proved to be essential for the catalytic 
activity of the HNH motif [129,130,132] it can also be con-
sidered to participate directly in the catalytic mechanism. 
Being a flexible residue, it may facilitate the proton transfer 
from the histidine general base towards the leaving alcoho-
late [133]. Such a role has been suggested recently in other 
hydrolytic enzymes [134,135].  
Not only the positive charges at the N-terminus, but also 
the amino acids with hydrophobic side-chains, such as the W 
tryptophan in NColE7 has a high impact on the catalysis by 
stabilizing the structure of the enzyme (and also the catalytic 
centre) through its interactions with a hydrophobic pocket, 
also involving residues from the HNH motif. It has been 
demonstrated, that the absence of this residue abolishes the 
metal ion binding within the active centre [126]. On the other 
hand, the protein folding and so the metal ion affinity is res-
cued by the interactions with the immunity protein or the 
DNA molecule [125,126]. It also has to be mentioned that 
the hydrolytic reaction is furthermore facilitated by the bend-
ing of the DNA [96] due to the protein-binding, to which the 
positively charged residues may contribute, as well.  
Recently it has been demonstrated that the mutation of 
the histidine residue behaving as the general base in the cata-
lytic reaction of the HNH nucleases led to the inactive en-
zyme, which however, become active in the presence of syn-
thetic imidazole [136]. Similarly, activation of the truncated 
N-terminal NColE7 inactive mutant was achieved to a vari-
ous extent in the presence of arginine or the KRNK tetrapep-
tide mimicking the deleted sequence (unpublished results). 
3. CONCLUSION 
The intriguing feature of certain HNH nucleases, such as 
the nuclease domains of colicins is that the residues deriving 
from the opposite end of the amino acid sequence to the ac-
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tive centre influence the catalytic process to a large extent. 
Individual inactive nuclease domains can be defined, which 
can be activated by the presence of appropriate protein seg-
ments. The necessity of, e.g. the N-terminal amino acids for 
the enzyme function provides a good opportunity to develop 
NColE7 into an artificial nuclease. The designed positive 
allosteric control is expected to greatly enhance the specific-
ity of the new enzyme [137]. In an enzyme of this kind the 
activation of the hydrolysis occurs only when the DNA rec-
ognizing domain binds to its specific target, precisely posi-
tioning the controlling sequence into the catalytic site (Fig. 
2). Any off-target cleavage arising from the non-specific 
binding of the zinc finger unit – even in the case of the even-
tual partial degradation within the cell – is expected to be 
precluded in such a nuclease, because the latter events result 
in loss of allosteric activation. 
 
Fig. (2). The schematic view of a designed allosteric control in an 
HNH-based artificial nuclease. The zinc finger protein (black) posi-
tions the HNH motif and the regulatory positively charged sequence 
(both in grey – the latter highlighted by sticks) into a functional 
complex around DNA (light grey). 
Furthermore, the fact that the missing essential residues 
or metal ions may be substituted by externally supplemented 
chemical agents, increases the chance to use the HNH nucle-
ase domains as strictly controlled agents in gene engineering. 
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